Results 221 to 230 of about 234,741 (400)

HLA MATCHING AND CADAVER KIDNEY TRANSPLANT SURVIVAL IN NORTH AMERICA

open access: bronze, 1977
Gerhard Opelz   +2 more
openalex   +1 more source

Principles of whole organ transplantation [PDF]

open access: yes, 1984
Iwatsuki, S, Shaw, BW, Starzl, TE
core  

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

open access: yesMolecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

The challenges of using ultrasound to measure the trachea: a brief report. [PDF]

open access: yesCrit Care
Newman H   +10 more
europepmc   +1 more source

The Mask Strikes Back: Blackness as Aporia in Moby-Dick and Benito Cereno

open access: yes, 2017
What is the American Gothic a reaction to? Whereas other thinkers such as Nathaniel Hawthorne locates the building blocks of the American Gothic in Puritan Christianity or Amerindian Genocide, I argue that Melville posits the genesis of chattel slavery ...
Clarke, Jerome D.
core  

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

open access: yesMolecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen   +12 more
wiley   +1 more source

TRANSPLANTATION OF MALIGNANT MELANOMA WITH CADAVER KIDNEY

open access: bronze, 1972
D. Jeremy   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy